| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 9.53 Billion | USD 26.72 Billion | 10.9% | 2024 |
FrequentlyAsked Questions
The Global prosthetic heart valve market is expected to grow due to rising prevalence of valvular heart diseases, an aging Global population, and continuous advancements in prosthetic valve technology and minimally invasive surgical procedures.
According to a study, the Global prosthetic heart valve market size was worth around USD 9.53 Billion in 2024 and is expected to reach USD 26.72 Billion by 2034.
The Global prosthetic heart valve market is expected to grow at a CAGR of 10.9% during the forecast period.
North America is expected to dominate the prosthetic heart valve market over the forecast period.
Leading players in the Global prosthetic heart valve market include Perouse Medical SAS, Colibri Heart Valve, LLC, Direct Flow Medical Inc, St. Jude Medical Inc, Cytograft Tissue Engineering Inc, Edwards Lifesciences Company, Heart Leaflet Technologies (HLT) Inc, The Sorin Group, among others.
The report explores crucial aspects of the prosthetic heart valve market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients